Ozempic promotes weight loss due to its active ingredient semaglutide, which mimics a hormone in the body called glucagon-like peptide-1 (GLP-1)
your clinician adjusts based on how you feel and your metabolic progress
Lipids in Health and Disease, 17 (1), 123
They are not generic versions of, or equivalent to, branded medications such as Ozempic, Wegovy, Mounjaro, or Zepbound
Future inquiries that build upon standardized depletion verification and FMT evidence quality, advancing along the path of Targeted Candidate Molecule ConvergenceRescue Verification of Sufficiency In Vivo Blocking Test of Necessity, and incorporating quantifiable frameworks like MicroecologyPharmacokinetics Interaction, will stand a far greater chance of forging a mechanistic evidence chain that is reproducible, falsifiable, and holds genuine translational value
Indeed, Novo Nordisk initially developed Ozempic to treat type 2 diabetes, and the Food and Drug Administration approved it for that use in 2017
